These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29559205)

  • 1. A clinical evaluation of placental growth factor in routine practice in high-risk women presenting with suspected pre-eclampsia and/or fetal growth restriction.
    Ormesher L; Johnstone ED; Shawkat E; Dempsey A; Chmiel C; Ingram E; Higgins LE; Myers JE
    Pregnancy Hypertens; 2018 Oct; 14():234-239. PubMed ID: 29559205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental Growth Factor informed management of suspected pre-eclampsia or fetal growth restriction: The MAPPLE cohort study.
    Sharp A; Chappell LC; Dekker G; Pelletier S; Garnier Y; Zeren O; Hillerer KM; Fischer T; Seed PT; Turner M; Shennan AH; Alfirevic Z
    Pregnancy Hypertens; 2018 Oct; 14():228-233. PubMed ID: 29627351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.
    Duhig KE; Myers J; Seed PT; Sparkes J; Lowe J; Hunter RM; Shennan AH; Chappell LC;
    Lancet; 2019 May; 393(10183):1807-1818. PubMed ID: 30948284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the PLGF in the prediction of the outcome in pregnancies with a small for gestational age fetus.
    Souka AP; Antsaklis P; Tassias K; Chatziioannou MA; Papamihail M; Daskalakis G
    Arch Gynecol Obstet; 2024 Jul; 310(1):237-243. PubMed ID: 37837546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implementation of the sFlt-1/PlGF ratio to identify preeclampsia and fetal growth restriction: A prospective cohort study.
    Herraiz I; Simón E; Gómez-Arriaga PI; Quezada MS; García-Burguillo A; López-Jiménez EA; Galindo A
    Pregnancy Hypertens; 2018 Jul; 13():279-285. PubMed ID: 30177066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal change of sFlt-1/PlGF ratio in singleton pregnancy with early-onset fetal growth restriction.
    Herraiz I; Quezada MS; Rodriguez-Calvo J; Gómez-Montes E; Villalaín C; Galindo A
    Ultrasound Obstet Gynecol; 2018 Nov; 52(5):631-638. PubMed ID: 28876491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Performance of Placental Growth Factor in Women With Suspected Preeclampsia Attending Antenatal Facilities in Maputo, Mozambique.
    Ukah UV; Mbofana F; Rocha BM; Loquiha O; Mudenyanga C; Usta M; Urso M; Drebit S; Magee LA; von Dadelszen P
    Hypertension; 2017 Mar; 69(3):469-474. PubMed ID: 28137987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early diagnosis of preeclampsia using placental growth factor: An operational pilot study in Maputo, Mozambique.
    Manriquez Rocha B; Mbofana F; Loquiha O; Mudenyanga C; Ukah UV; Magee LA; von Dadelszen P
    Pregnancy Hypertens; 2018 Jan; 11():26-31. PubMed ID: 29523269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age.
    Garcia-Manau P; Mendoza M; Bonacina E; Garrido-Gimenez C; Fernandez-Oliva A; Zanini J; Catalan M; Tur H; Serrano B; Carreras E
    Acta Obstet Gynecol Scand; 2021 Jan; 100(1):119-128. PubMed ID: 32860218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental growth factor as an indicator of fetal growth restriction in late-onset small-for-gestational age pregnancies.
    Anderson N; De Laat M; Benton S; von Dadelszen P; McCowan L
    Aust N Z J Obstet Gynaecol; 2019 Feb; 59(1):89-95. PubMed ID: 29851029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of Kryptor and Elecsys® immunoassay sFlt-1/PlGF ratio on early diagnosis of preeclampsia and fetal growth restriction: A case-control study.
    Simón E; Herraiz I; Villalaín C; Gómez-Arriaga PI; Quezada MS; López-Jiménez EA; Galindo A
    Pregnancy Hypertens; 2020 Apr; 20():44-49. PubMed ID: 32172169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of placental growth factor in twin pregnancy and development of a dichorionic twin pregnancy specific reference range.
    Hayes-Ryan D; Meaney S; Fitzgerald AP; O'Mahony E; Normile C; Kenny LC; O'Donoghue K
    BJOG; 2021 Jan; 128(2):411-419. PubMed ID: 32946654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction.
    Benton SJ; McCowan LM; Heazell AE; Grynspan D; Hutcheon JA; Senger C; Burke O; Chan Y; Harding JE; Yockell-Lelièvre J; Hu Y; Chappell LC; Griffin MJ; Shennan AH; Magee LA; Gruslin A; von Dadelszen P
    Placenta; 2016 Jun; 42():1-8. PubMed ID: 27238707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of preterm birth in growth-restricted and appropriate-for-gestational-age infants using maternal PlGF and the sFlt-1/PlGF ratio-A prospective study.
    Hong J; Crawford K; Cavanagh E; da Silva Costa F; Kumar S
    BJOG; 2024 Jul; 131(8):1089-1101. PubMed ID: 38196326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic indicators of severe disease in late preterm pre-eclampsia to guide decision making on timing of delivery: The PEACOCK study.
    Duhig KE; Seed PT; Placzek A; Sparkes J; Hendy E; Gill C; Brockbank A; Shennan AH; Thangaratinam S; Chappell LC
    Pregnancy Hypertens; 2021 Jun; 24():90-95. PubMed ID: 33770588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis.
    Shen L; Martinez-Portilla RJ; Rolnik DL; Poon LC
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):546-552. PubMed ID: 33998099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of serum-circulating angiogenic factors within 1 week prior to delivery are closely related to conditions of pregnant women with pre-eclampsia, gestational hypertension, and/or fetal growth restriction.
    Nanjo S; Minami S; Mizoguchi M; Yamamoto M; Yahata T; Toujima S; Shiro M; Kobayashi A; Muragaki Y; Ino K
    J Obstet Gynaecol Res; 2017 Dec; 43(12):1805-1814. PubMed ID: 28929598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of preterm birth in women with fetal growth restriction - Is the weekly change in sFlt-1/PlGF ratio or PlGF levels useful?
    Hong J; Crawford K; Cavanagh E; Clifton V; Kumar S
    Acta Obstet Gynecol Scand; 2024 Jun; 103(6):1112-1119. PubMed ID: 38483020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. sFlt-1 to PlGF ratio cut-offs to predict adverse pregnancy outcomes in early-onset FGR and SGA: a prospective observational study.
    Bonacina E; Armengol-Alsina M; Hurtado I; Garcia-Manau P; Ferrer-Oliveras R; Monreal S; Pancorbo M; Mendoza M; Carreras E
    J Obstet Gynaecol; 2022 Oct; 42(7):2840-2845. PubMed ID: 35980876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.